Status:
COMPLETED
Coload Optimization Guided by Inferior Vena Cava Collapsibility Index
Lead Sponsor:
General Hospital of Ningxia Medical University
Conditions:
Adverse Effect
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the optimal coload guided by inferior vena cava collapsibility index in parturients with prophylactic norepinephrine infusion undergoing cesarean section.
Detailed Description
Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylacti...
Eligibility Criteria
Inclusion
- 18-40 years
- Primipara or multipara
- Singleton pregnancy ≥37 weeks
- American Society of Anesthesiologists physical status classification I to II
- Scheduled for elective cesarean section under spinal anesthesia
Exclusion
- Body height \< 150 cm
- Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
- Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg
- Hemoglobin \< 7g/dl
- Fetal distress, or known fetal developmental anomaly
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2021
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT04272632
Start Date
April 1 2021
End Date
November 25 2021
Last Update
November 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China, 750004